SRI-011381
CAS: 1629138-41-5
Ref. 3D-EQC13841
| 2mg | 136.00 € | ||
| 5mg | 167.00 € | ||
| 10mg | 234.00 € | ||
| 25mg | 352.00 € | ||
| 50mg | 470.00 € |
Product Information
SRI-011381 is a novel small molecule inhibitor of the ubiquitin proteasome pathway. It inhibits the degradation of proteins by inhibiting the activity of the ubiquitin proteasome, which is required for protein synthesis. SRI-011381 has been shown to inhibit tumor growth in vivo and in vitro, as well as prevent the development of cancer tissues. This drug also has anti-inflammatory properties and may be useful for treating idiopathic urticaria. SRI-011381 has strong antimicrobial activity against Gram-positive bacteria, such as methicillin resistant Staphylococcus aureus (MRSA) and Bacillus cereus. It also inhibits growth factor β1, which is responsible for proliferation in cells with metabolic disorders.
Chemical properties
Technical inquiry about: 3D-EQC13841 SRI-011381
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
